SCHEMBL10324481

SCHEMBL10324481

Cc1nn(C2CCCCO2)c2ccc(C(=O)O)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.44
HCAR3 P49019 4/20 0.43
PDE7A Q13946 1/20 0.42
TEAD1 P28347 1/20 0.42
TEAD4 Q15561 1/20 0.42
TEAD2 Q15562 1/20 0.42
RXRA P19793 1/20 0.42
RXRB P28702 1/20 0.42
RXRG P48443 1/20 0.42
HSD17B10 Q99714 3/20 0.41
GAA P10253 2/20 0.41
CYP4F2 P78329 2/20 0.40
CYP4A11 Q02928 2/20 0.40
RAB9A P51151 1/20 0.40
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
TSHR P16473 1/20 0.40
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30040921 1.00 L3MBTL1 (0.44) L3MBTL1HCAR3PDE7ATEAD1TEAD4
Lithium SCHEMBL30864302 0.99 L3MBTL1 (0.43) L3MBTL1HCAR3PDE7ATEAD1TEAD4
SCHEMBL23535794 0.91 NPC1 (0.41) L3MBTL1RXRARXRBRXRGGAA
SCHEMBL30040126 0.91 NPC1 (0.41) L3MBTL1RXRARXRBRXRGGAA
SCHEMBL23535814 0.90 SLC22A12 (0.46) L3MBTL1HCAR3PDE7ARXRARXRB
SCHEMBL30041514 0.90 SLC22A12 (0.46) L3MBTL1HCAR3PDE7ARXRARXRB
Lithium Ion SCHEMBL30159606 0.90 CYP4F2 (0.38) L3MBTL1HCAR3PDE7ATEAD1TEAD4
Lithium Ion SCHEMBL28962278 0.90 CYP4F2 (0.38) L3MBTL1HCAR3PDE7ATEAD1TEAD4
SCHEMBL10324149 0.89 DGAT2 (0.40) PDE7ARXRARXRBRXRGGAA
SCHEMBL30159592 0.89 DGAT2 (0.40) PDE7ARXRARXRBRXRGGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY 2023-01-26 US disclosed
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY 2023-01-26 US disclosed
CN-115427035-A ENL/AF9YEATS inhibitors 洛克菲勒大学 2022-12-02 CN disclosed
EP-4076440-A1 INHIBITORS OF ENL/AF9 YEATS The Rockefeller University (US) 2022-10-26 EP disclosed
WO-2021127166-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY (US) 2021-06-24 WO disclosed
WO-2021127166-A1 INHIBITORS OF ENL/AF9 YEATS THE ROCKEFELLER UNIVERSITY (US) 2021-06-24 WO disclosed
WO-2020192588-A1 ALKYLSULFAMOYL INDAZOLE CARBOXAMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL USE THEREOF 上海海雁医药科技有限公司 2020-10-01 WO disclosed
WO-2012095781-A1 INDAZOLE DERIVATIVES AS SODIUM CHANNEL INHIBITORS PFIZER LIMITED (GB) 2012-07-19 WO disclosed
WO-2012095781-A1 INDAZOLE DERIVATIVES AS SODIUM CHANNEL INHIBITORS PFIZER LIMITED (GB) 2012-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230027198-A1 INHIBITORS OF ENL/AF9 YEATS MLLT3, YEATS2, MLLT1 L3MBTL1 410/4885HCAR3 1553/4885PDE7A 3989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.